| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/25/2013 | CN103463627A Oral care composition containing heat-resistant superoxide dismutase and growth factors |
| 12/25/2013 | CN103463626A HO-1 and HO-1 inducer for inhibiting PRRS virus (PRRSV) infection as novel blocker |
| 12/25/2013 | CN103463625A Nutraceutical for nourishing heart and replenishing blood |
| 12/25/2013 | CN103463624A Bone joint composite nutrient supplement and preparation method thereof |
| 12/25/2013 | CN103463623A Pegylated interferon injection and preparation method thereof |
| 12/25/2013 | CN103463622A Use of tabancus yao macquart antithrombotic polypeptide vasotab TY |
| 12/25/2013 | CN103463621A NA+/K+-Atpase-specific peptide inhibitors/activators of Src and Src family kinases |
| 12/25/2013 | CN103463620A Application of anti-inflammatory protein TIPE2 in preparation of medicines used for treating atherosclerosis |
| 12/25/2013 | CN103463619A Application of bone morphogenetic protein 4 in cancer inhibition |
| 12/25/2013 | CN103463618A Application of recombinant ganoderma lucidum immunoregulatory protein in preparing drug for treating focal cerebral ischemia |
| 12/25/2013 | CN103463617A Method for synthesizing targeting radioiodine labeled thyroglotulin nano capsule |
| 12/25/2013 | CN103463616A Chitosan and tripeptide composition as well as preparation method and application thereof |
| 12/25/2013 | CN103463615A Blood pressure lowering peptides from glycomacropeptide |
| 12/25/2013 | CN103463614A Argatroban injection and preparation method thereof |
| 12/25/2013 | CN103463133A Material including royal jelly-decomposing enzyme |
| 12/25/2013 | CN103461996A Toxin expelling, oxygenation and healthcare element capsule |
| 12/25/2013 | CN103461676A Feed additive comprising lysozyme, pesticide composition and application of feed additive |
| 12/25/2013 | CN102920998B Application of Chinese yarn glycoprotein in improvement of activities of oxidative metabolism enzymes of mitochondria of brain cell |
| 12/25/2013 | CN102796197B Human serum albumin-granulocyte colony stimulating factor (HAS-GCSF) mutant and preparation method thereof |
| 12/25/2013 | CN102603868B Synthetic polypeptide and application of synthetic polypeptide |
| 12/25/2013 | CN102579313B External liquid preparation capable of preventing secondary chromatosis from happening after skin trauma operations |
| 12/25/2013 | CN102552890B Medicinal composition of recombinant carboxypeptidase G2 |
| 12/25/2013 | CN102532297B Ancylostoma caninum anticoagulant peptide and preparation and application thereof |
| 12/25/2013 | CN102526714B Medicine composition for curing tumour and preparation method thereof |
| 12/25/2013 | CN102453077B Fluoronosiheptide and preparation method and application thereof |
| 12/25/2013 | CN102441159B Application of human polypeptide in preparation of immune regulator |
| 12/25/2013 | CN102416171B Protective agent in process for performing dry heat virus inactivation on high-purity prothrombin complex concentrate products |
| 12/25/2013 | CN102389030B Purpose of bacillus subtilis glycopeptide 168 |
| 12/25/2013 | CN102372766B O-type foot-and-mouth disease multi-epitope vaccine |
| 12/25/2013 | CN102311502B Fusion protein used for inhibiting regeneration or growth of blood vessel and medical treatment application thereof |
| 12/25/2013 | CN102058872B Medicinal composition containing Lysinopril and amlodipine besilate and preparation method thereof |
| 12/25/2013 | CN102049048B Method of treatment or prophylaxis |
| 12/25/2013 | CN101787073B Methods and compositions for treatment of gastrointestinal disorders |
| 12/25/2013 | CN101678079B Modified erythropoietin polypeptides and uses thereof for treatment |
| 12/25/2013 | CN101648002B Medicinal composition for treating skin injury and ulcer and application thereof |
| 12/25/2013 | CN101631560B Use of pegylated IL-10 to treat cancer |
| 12/24/2013 | US8614293 Concentrated aqueous silk fibroin solution and use thereof |
| 12/24/2013 | US8614292 Isolated protein comprising an activin type IIB5 receptor polypeptide and uses thereof |
| 12/24/2013 | US8614291 Phosphorylated polymers and conjugates thereof |
| 12/24/2013 | US8614289 Processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| 12/24/2013 | US8614194 Anionic cell penetrating peptide and its use for intracellular delivery |
| 12/24/2013 | US8614193 Depsipeptides and their therapeutic use |
| 12/24/2013 | US8614192 Method for treating ocular cancer |
| 12/24/2013 | US8614191 Use of ICAM-1 for prevention or treatment of neurological diseases |
| 12/24/2013 | US8614190 Thermal responsive composition for treating bone diseases |
| 12/24/2013 | US8614189 Carbon nanotube composite scaffolds for bone tissue engineering |
| 12/24/2013 | US8614188 Inhibiting collagen-induced platelet aggregation and activation with peptide variants |
| 12/24/2013 | US8614187 Peptides, compositions and uses thereof |
| 12/24/2013 | US8614186 Inhibition of inflammation using antagonists of MUC1 |
| 12/24/2013 | US8614185 Fusion proteins of alpha-MSH derivatives and Fc |
| 12/24/2013 | US8614184 HCG formulations for achieving weight loss |
| 12/24/2013 | US8614183 Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2 |
| 12/24/2013 | US8614182 GLP-1 analogues and their pharmaceutical salts and uses |
| 12/24/2013 | US8614181 Stabilized pharmaceutical peptide compositions |
| 12/24/2013 | US8614179 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 12/24/2013 | US8614178 Pharmaceutical composition for treatment of dry eye syndrome |
| 12/24/2013 | US8614177 Peptides |
| 12/24/2013 | US8614176 Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides |
| 12/24/2013 | US8614103 Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions |
| 12/24/2013 | US8613931 Compounds for treating beta-amyloidoses |
| 12/24/2013 | US8613929 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers |
| 12/24/2013 | US8613923 Monoclonal antibody |
| 12/24/2013 | US8613918 Method for treating pervasive development disorders |
| 12/24/2013 | US8613907 Compositions that inhibit proliferation of cancer cells |
| 12/24/2013 | US8613903 Humanized L243 antibodies |
| 12/24/2013 | CA2623529C Pdgf amphiphilic polymer complex |
| 12/24/2013 | CA2621577C Methods and compositions for oral administration of proteins |
| 12/24/2013 | CA2609812C Angiotensin i-converting enzyme (ace) inhibitors |
| 12/24/2013 | CA2601784C Acylated glp-1 compounds |
| 12/24/2013 | CA2587188C Pharmaceutical preparation for the treatment of friedreich's ataxia |
| 12/24/2013 | CA2555393C Hybrid proteins of active-site serine beta-lactamase |
| 12/24/2013 | CA2529307C Methods and compositions for the treatment of gastrointestinal disorders |
| 12/24/2013 | CA2520372C Stq-peptides |
| 12/24/2013 | CA2516550C Production of modified glycoproteins having multiple antennary structures |
| 12/24/2013 | CA2487915C Allergen from mugwort pollen |
| 12/24/2013 | CA2464199C A composition and method to alter lean body mass and bone properties in a subject |
| 12/24/2013 | CA2397199C Nogo receptor-mediated blockade of axonal growth |
| 12/24/2013 | CA2395945C Novel chimeric proteins and methods for using the same |
| 12/24/2013 | CA2375104C Prevention and treatment of amyloidogenic disease |
| 12/24/2013 | CA2349762C Human tslp dna and polypeptides |
| 12/19/2013 | WO2013188874A1 Methods of mitigating side effects of radiation exposure and chemotherapy |
| 12/19/2013 | WO2013188873A1 Compositions and methods for enhancing immune responses |
| 12/19/2013 | WO2013188806A1 Sleep apnea treatment |
| 12/19/2013 | WO2013188794A1 Novel microcin and uses thereof |
| 12/19/2013 | WO2013188676A2 Intranasal delivery of cell permeant therapeutics for the treatment of edema |
| 12/19/2013 | WO2013188607A1 One step n-terminal tagging of proteins |
| 12/19/2013 | WO2013188497A2 A smart, self-decontaminating polymer and method for inhibiting the growth of a bacteria and fungus |
| 12/19/2013 | WO2013188203A1 Staphylococcal phage2638a endolysin amidase domain is lytic for staphylococcus aureus |
| 12/19/2013 | WO2013188182A1 Fibroblast growth factor 21 variants |
| 12/19/2013 | WO2013188181A1 Fibroblast growth factor 21 proteins |
| 12/19/2013 | WO2013188016A2 Surfactant therapy for exposure to ionizing radiation |
| 12/19/2013 | WO2013187984A1 Compositions and methods for enhancing the efficacy of contraceptive microbicides |
| 12/19/2013 | WO2013187906A1 Nucleic acids for treatment of allergies |
| 12/19/2013 | WO2013187899A1 Compositions and methods for stimulating wound healing |
| 12/19/2013 | WO2013187891A1 Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells |
| 12/19/2013 | WO2013187730A1 Composition for preventing or treating fracture or osteoporosis using slit-robo system |
| 12/19/2013 | WO2013187612A1 Composition for restricting apoptosis, including mirna of epstein-barr virus, or promoting cell proliferation |
| 12/19/2013 | WO2013187552A1 Anti-inflammatory composition comprising alloferon and cosmetic composition comprising same |
| 12/19/2013 | WO2013187381A1 Method for producing ppar activator, and ppar activator |
| 12/19/2013 | WO2013186793A1 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells |